dan 2163 has been researched along with Dyskinesia, Drug-Induced in 29 studies
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this long-term, open, randomised, multicentre trial, patients with chronic or subchronic schizophrenia received amisulpride (n =370) or haloperidol (n = 118) for 12 months." | 5.09 | Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group. ( Colonna, L; Dondey-Nouvel, L; Rein, W; Saleem, P, 2000) |
| "Following ten years of continuous olanzapine therapy a 51 years old man developed a Gilles de la Tourette syndrome which disappeared after changing to amisulprid." | 3.74 | [Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia]. ( Friederich, M; Kozian, R, 2007) |
| " Extrapyramidal tolerability was better in the ASP group, as demonstrated by smaller increases in the Simpson-Angus Scale, the AIMS, and the Barnes Akathisia Scale in ANCOVA analyses with dosage as covariate." | 2.69 | Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group. ( Adler, G; Benkert, O; Gattaz, WF; Gründer, G; Hillert, A; Philipp, M; Rein, W; Sauer, H; Schröder, J; Wetzel, H, 1998) |
| "Risperidone appears to be an effective therapy, but several authors report cases of TD during treatment." | 2.41 | Tardive dyskinesias and antipsychotics: a review. ( Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM, 2002) |
| "Although schizophrenia affects all age groups, late or very-late-onset schizophrenia-like psychosis has not been well studied and various treatment issues remain unresolved." | 1.35 | Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis. ( Papadimitriou, GN; Paparrigopoulos, TJ; Politis, AM; Psarros, C; Theleritis, CG, 2009) |
| "Aripiprazole is a new generation antipsychotic drug with a partial agonist effect on dopamine D2 and D3 receptors." | 1.35 | Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. ( Adan-Manes, J; Garcia-Parajua, P, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.90) | 18.7374 |
| 1990's | 3 (10.34) | 18.2507 |
| 2000's | 17 (58.62) | 29.6817 |
| 2010's | 7 (24.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erguner Aral, A | 1 |
| Ozberk, B | 1 |
| Sarisoy, G | 1 |
| Sevincok, L | 1 |
| Balci, V | 1 |
| Akyildiz, U | 1 |
| Psarros, C | 1 |
| Theleritis, CG | 1 |
| Paparrigopoulos, TJ | 1 |
| Politis, AM | 1 |
| Papadimitriou, GN | 1 |
| Adan-Manes, J | 1 |
| Garcia-Parajua, P | 1 |
| Mendhekar, DN | 3 |
| Andrade, C | 2 |
| Rizos, E | 1 |
| Douzenis, A | 1 |
| Gournellis, R | 1 |
| Christodoulou, C | 1 |
| Lykouras, LP | 1 |
| Guriz, O | 1 |
| Ekinci, AE | 1 |
| Orsel, S | 1 |
| Ekinci, O | 1 |
| Goyal, N | 1 |
| Sinha, VK | 1 |
| Chen, CC | 1 |
| Chen, YY | 1 |
| Hung, GC | 1 |
| Lee, SJ | 1 |
| Lee, JH | 1 |
| Jung, SW | 1 |
| Koo, BH | 1 |
| Choi, TY | 1 |
| Lee, KH | 1 |
| Correll, CU | 1 |
| Leucht, S | 1 |
| Kane, JM | 1 |
| Müller, JL | 1 |
| Putzhammer, A | 1 |
| Hajak, G | 1 |
| Müller, MJ | 1 |
| Regenbogen, B | 1 |
| Härtter, S | 1 |
| Eich, FX | 2 |
| Hiemke, C | 1 |
| Fountoulakis, KN | 1 |
| Panagiotidis, P | 1 |
| Siamouli, M | 1 |
| Kantartzis, S | 1 |
| Mavridis, T | 1 |
| Iacovides, A | 1 |
| Kaprinis, G | 1 |
| Limosin, F | 1 |
| Linden, M | 1 |
| Pyrkosch, L | 1 |
| Kozian, R | 1 |
| Friederich, M | 1 |
| Leclere, A | 1 |
| Plichart, P | 1 |
| Freeman, HL | 1 |
| Wetzel, H | 1 |
| Gründer, G | 1 |
| Hillert, A | 1 |
| Philipp, M | 1 |
| Gattaz, WF | 1 |
| Sauer, H | 1 |
| Adler, G | 1 |
| Schröder, J | 1 |
| Rein, W | 2 |
| Benkert, O | 1 |
| Colonna, L | 1 |
| Saleem, P | 1 |
| Dondey-Nouvel, L | 1 |
| Naber, D | 1 |
| Möller, HJ | 1 |
| Marchese, G | 1 |
| Casu, MA | 1 |
| Bartholini, F | 1 |
| Ruiu, S | 1 |
| Saba, P | 1 |
| Gessa, GL | 1 |
| Pani, L | 1 |
| Llorca, PM | 1 |
| Chereau, I | 1 |
| Bayle, FJ | 1 |
| Lancon, C | 1 |
| Boyer, P | 1 |
| Lecrubier, Y | 1 |
| Puech, AJ | 1 |
| Amore, M | 1 |
| Cerisoli, M | 1 |
| Campanile, S | 1 |
| Campanile, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia[NCT00595504] | Phase 4 | 25 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A comparison between the ramelteon group and the placebo group of change in abdominal fat measured by a DEXA scan, assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | g (Mean) |
|---|---|
| Ramelteon | 3934.86 |
| Placebo (Sugar Pill) | 5120.92 |
A comparison between the ramelteon group and the placebo group of change in insulin resistance measured by the homeostatic model assessment of insulin resistance (HOMA-IR), assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | HOMA score (Mean) |
|---|---|
| Ramelteon | 2.4 |
| Placebo (Sugar Pill) | 2.36 |
A comparison between the ramelteon group and the placebo group in change in waist circumference (measured in cm) measured at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | cm (Mean) |
|---|---|
| Ramelteon | 106.09 |
| Placebo (Sugar Pill) | 108.37 |
5 reviews available for dan 2163 and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepin | 2004 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; | 2006 |
Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double- | 1997 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; | 2000 |
Tardive dyskinesias and antipsychotics: a review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Ola | 2002 |
4 trials available for dan 2163 and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
Topics: Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Disea | 2012 |
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Dru | 1998 |
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Chronic Disease; Dyskinesia, Drug-Induce | 2000 |
Treatment of positive and negative symptoms: pharmacologic approaches.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug | 1990 |
20 other studies available for dan 2163 and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Rabbit syndrome as a side effect triggered by amisulpride.
Topics: Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Jaw; Li | 2019 |
Tardive dystonia associated with low-dose of amisulpride: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Dystonia; Humans; Mal | 2008 |
Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
Topics: Age of Onset; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; | 2009 |
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
Topics: Amisulpride; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Biperiden; Dopamine; Drug T | 2009 |
Amisulpride-induced tardive dyskinesia and possible association of dyskinesia with hypothyroidism.
Topics: Amisulpride; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Hypothyroidism; Male; Sulpiride | 2009 |
Tardive dyskinesia in a patient treated with quetiapine.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskine | 2009 |
Amisulpride-induced tardive dystonia: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Electroencephalography | 2010 |
Amisulpride-induced tardive dyskinesia in childhood onset schizophrenia.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Schizophrenia | 2010 |
Tardive dystonia induced by switch of atypical antipsychotics.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Female; Hum | 2010 |
Possible rabbit syndrome with amisulpride.
Topics: Aged; Amisulpride; Dyskinesia, Drug-Induced; Humans; Male; Sulpiride | 2010 |
Amisulpride may worsen dyskinesia and trigger new-onset dyskinetic movements.
Topics: Aged; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Schizophrenia; Su | 2010 |
[Functional magnetic resonance tomography of central motor areas in schizophrenic patients].
Topics: Amisulpride; Antipsychotic Agents; Biomechanical Phenomena; Dyskinesia, Drug-Induced; Gait Apraxia; | 2005 |
Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Dose-Response Relatio | 2007 |
Amisulpride-induced tardive dyskinesia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Dru | 2006 |
Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Utilization; Dyskinesia, | 2007 |
[Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Dyskinesia, Drug-Indu | 2007 |
[Use of sultopride in a case of neuroleptic-induced late dyskinesia].
Topics: Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Sulpiride | 1982 |
[Atypical antipsychotics].
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; | 2000 |
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
Topics: Amisulpride; Animals; Antipsychotic Agents; Clozapine; Dopamine; Dose-Response Relationship, Drug; D | 2002 |
Pisa syndrome. Report of a case.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Schiz | 1988 |